Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Goldman Sachs Group (NY: GS )

492.36 -5.66 (-1.14%)
Streaming Delayed Price Updated: 3:27 PM EDT, Sep 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Goldman Sachs Group

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Goldman Sachs Q2 Earnings: Revenue And EPS Beat, Investment Banking Fees Up 21%, Dividend Hike
Goldman Sachs Group Inc (NYSE:GS) reported Q2 revenue of $12.73B, beating consensus of $12.46B. Sales increased 17% Y/Y, driven by Global Banking & Markets and Asset & Wealth Management. 
Via Benzinga
US Stocks Poised For Positive Start Ahead Of Powell's Speech, Earnings: DJT Soars As Trump's Odds Improve Following Rally Shooting
U.S. stocks look set to start the fresh week on a positive note, unperturbed by elevated valuations they have amassed, especially the mega-caps. 
Via Benzinga
Topics Government
Exposures Political
Goldman Sachs, BlackRock And 3 Stocks To Watch Heading Into Monday
Via Benzinga
US Stocks Close Higher, Dow Hits 40,000: Market Sentiment Remains In Greed Zone
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, with the index remaining in the "Greed" zone on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Check Out What Whales Are Doing With Goldman Sachs Gr
Via Benzinga
Netflix, Goldman Sachs, J&J, ASML Lead Q2 Reports This Week As Analysts See Earnings Growth Accelerating To Fastest In Over 2 Years
Following a lackluster big bank earnings, market participants now turn their attention to the unfolding week, expecting the trend to reverse. 
Via Benzinga
Nvidia CEO Jensen Huang Sold $169 Million in Stock During the First Half of 2024. Time to Worry?
Are the sales a sign of overvaluation? Or just business as usual? 
Via The Motley Fool
Sanofi's $20B Consumer Health Unit Sale: Goldman Sachs, Morgan Stanley Line Up $6.5B Financing
Explore the €6 billion financing effort by banks for Sanofi's consumer health division sale. Discover the latest in high-stakes pharmaceutical industry deals. 
Via Benzinga
JPMorgan, Standard Chartered-Backed Blockchain Fintech Partior Secures $60M In Venture Capital
Partior intends to use the new capital to enhance its ledger-based interbank rails for real-time clearing and settlement. 
Via Benzinga
Goldman Sachs' Bullish Surge Ahead Of Q2 Earnings: How The Stock Maps Against Wall Street Estimates
Goldman Sachs exhibits a robust bullish trend; its share price of $479.50 is above its 5, 20, and 50-day exponential moving averages. 
Via Benzinga
Goldman Sachs Likely To Report Surge In Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Hong Kong's WH Group Subsidiary Smithfield Foods Gears Up For $1B IPO In US: Report
The group acquired Smithfield in 2013, and the combined firm went public in Hong Kong in 2014 after raising more than $2 billion. 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
JPMorgan, Citi Kick Off Big Bank Reporting Season As Expectations Remain Muted Amid Economic Headwinds: Q2 Earnings Preview
Bank earnings are important not just for the implication for the stocks of these companies but they also are seen as indicator of the health of the economy. 
Via Benzinga
Topics Economy
Exposures Economy
PepsiCo Q2 Earnings Were Softer Than Expected Due To Volume Pressure: Goldman Sachs
Goldman Sachs analyst Bonnie Herzog reiterated a Buy rating for PepsiCo with a $195 price target. Despite mixed Q2 results, strong gross margin expansion led to an EPS beat. The analyst expects PepsiCo... 
Via Benzinga
10 Financials Stocks With Whale Alerts In Today's Session
Via Benzinga
The 3 Most Undervalued Dow Stocks to Buy in July 2024
The venerable index is lagging far behind the performance of the S&P 500, meaning there are undervalued Dow stocks to buy. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
JPMorgan, Citigroup In Buy Zone With Bank Earnings On Tap
Wells Fargo, just below a buy point, also reports Friday morning. 
Via Investor's Business Daily
Trump Win In November Will Boost The Stock Market, Says Goldman Sachs, But Not All Sectors Will Benefit
Goldman Sachs analysts have suggested that a Donald Trump victory in the 2024 presidential election could be beneficial for the stock market, but not all sectors will see the same impact. 
Via Benzinga
Topics Government
Exposures Political
3 Underpriced Stocks Primed for a July Breakout
A July breakout may be in the works for the following still-underpriced stocks as investors appreciate their recent results. 
Via InvestorPlace
The 3 Most Undervalued Renewable Energy Stocks to Buy in July 2024
Best-in-class candidates for undervalued renewable energy stocks include RUN, CSIQ and NPIFF. Don't miss out! 
Via InvestorPlace
Goldman Sachs To Launch Three Tokenization Projects By Year-End: 'It'll Change The Nature Of How Clients Can Invest'
Goldman Sachs' new tokenization projects are driven by client demand. It sees potential for more growth in the crypto space. 
Via Benzinga
2024: Top-Heavy, AI-Fueled, Supply-Constrained
It's Motley Fool Money's midyear review show! We talk through the market's strong start in 2024, how it's being driven by the big names, and where the deals might be. 
Via The Motley Fool
Goldman Sachs Just Raised Its Tesla (TSLA) Stock Price Target
Goldman Sachs has raised its price target on TSLA stock. Here's what investors need to know about shifting Wall Street sentiment. 
Via InvestorPlace
Panther Minerals (OTC: GLIOF) May Be Poised To Benefit Amid Nuclear Power Push For AI Data Center Growth
Panther Minerals (OTC: GLIOF) May Be Poised To Benefit Amid Nuclear Power Push For AI Data Center Growth 
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Eli Lilly's acquisition of Morphic highlights strategic expansion in Immunology, targeting α4β7 for ulcerative colitis and Crohn's disease treatments. Goldman Sachs notes the deal's potential to... 
Via Benzinga
S&P 500 Hits Record Highs, Eyes 6th Straight Gain As Powell Keeps Bears At Bay; Tesla Targets 10th Consecutive Win, Bank Stocks Rally: What's Driving Markets Tuesday?
The S&P 500 index climbed to new all-time highs, rising 0.3% during Tuesday’s session, aiming for a potential sixth consecutive positive close and remaining resilient after Fed Chair Jerome Powell‘s... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Trump's Deregulation Agenda: Oil & Gas, Defense, And Finance Stocks May Benefit From Loose Rules, Goldman Sachs Says
Goldman Sachs predicts a Trump win would lead to deregulation in energy, utilities, financials, healthcare, industrials, materials, and telecom sectors, while consumer discretionary, staples, tech, and... 
Via Benzinga
Topics Government
Exposures Political
US Federal Reserve Considers Rule Change To Save Largest Banks Billions In Capital: Report
The U.S. Federal Reserve is considering a rule revision that could save major banks billions in capital. This change targets the "GSIB surcharge" imposed on global systemically important banks (GSIBs)... 
Via Benzinga
Topics Economy
Exposures Interest Rates
The 3 Most Undervalued Chinese Stocks to Buy in July 2024
Chinese stocks seem positively aligned and ready to amass gains. Consider these three gems if you share the same view! 
Via InvestorPlace
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
This pharma company is posting double-digit revenue growth. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.